PPARGC1A and Mitochondrial myopathy: For these reasons, the hypothesis that targeting PGC-1α and/or activating mitochondrial biogenesis could overcome the effect of mtDNA or nuclear mutations by rescuing the phenotype of mitochondrial myopathy has been explored for decades but mainly in mice models.